logo

Insmed Inc (INSM)



Trade INSM now with
  Date
  Headline
4/7/2022 8:02:41 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3/4/2022 8:01:53 AM Insmed Announces Inducement Grants Under NASDAQ Listing Rule
2/17/2022 7:11:41 AM Insmed Q4 Net Loss $113 Mln Vs. Net Loss $102.2 Mln Last Year
10/28/2021 7:40:02 AM Insmed Q3 Total Revenue $46.8 Mln Vs. $43.6 Mln Prior Year
10/5/2021 8:08:35 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
9/3/2021 8:03:04 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8/6/2021 8:01:47 AM Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
8/5/2021 7:42:40 AM Insmed Q2 Total Revenue $45.4 Mln Vs. $42.5 Mln Prior Year
7/8/2021 8:07:18 AM Insmed Announces Granting Of Inducement Awards To 12 New Employees
5/11/2021 2:58:57 AM Insmed Prices Public Offering Of 10 Mln Shares At $25/Shr And Convertible Senior Notes Due 2028
5/10/2021 7:03:28 AM Insmed To Sell $250 Mln Of Its Common Stock
3/23/2021 5:24:37 AM Insmed: ARIKAYCE Approved In Japan NTM Lung Disease Caused By MAC Who Did Not Respond To Prior Care With MDR
2/25/2021 8:24:28 AM Insmed Inc Q4 Net Loss $102.2 Mln Vs. Net Loss $53.0 Mln Last Year
2/19/2021 7:31:38 AM Insmed Announces Topline Results From Phase 1 Study Of Treprostinil Palmitil Inhalation Powder